First Light Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

First Light Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-179,601	Closed	-$10.2M	–	84
2020 Q4	$10.2M	Buy	+179,601	New	+$8.95M	0.75%	33
2020 Q3	–	Sell	-129,832	Closed	-$7.66M	–	63
2020 Q2	$7.66M	Sell	129,832 -66,018	-34%	-$3.67M	0.89%	33
2020 Q1	$9.26M	Sell	195,850 -47,841	-20%	-$2.67M	1.58%	22
2019 Q4	$14.7M	Sell	243,691 -80,958	-25%	-$4.82M	1.88%	19
2019 Q3	$19.4M	Sell	324,649 -2,483	-0.8%	-$162K	2.94%	14
2019 Q2	$21M	Sell	327,132 -284,030	-46%	-$20.1M	2.92%	11
2019 Q1	$49.6M	Buy	611,162 +21,152	+4%	+$1.36M	6.45%	2
2018 Q4	$31.9M	Buy	590,010 +97,870	+20%	+$4.99M	5.09%	5
2018 Q3	$25.4M	Sell	492,140 -2,207	-0.4%	-$104K	4.1%	9
2018 Q2	$20.6M	Buy	494,347 +451,883	+1,064%	+$20M	3.21%	13
2018 Q1	$1.87M	Buy	42,464 +617	+1%	+$31.3K	0.41%	38
2017 Q4	$2.1M	Sell	41,847 -664	-2%	-$36.4K	0.58%	36
2017 Q3	$2.15M	Buy	42,511 +496	+1%	+$26K	0.68%	37
2017 Q2	$2.14M	Sell	42,015 -8,174	-16%	-$381K	0.72%	34
2017 Q1	$2.02M	Buy	50,189 +731	+1%	+$32.8K	0.77%	34
2016 Q4	$2.37M	Sell	49,458 -1,324	-3%	-$52.4K	1.04%	31
2016 Q3	$1.86M	Buy	+50,782	New	+$1.59M	0.8%	40
2015 Q1	–	Sell	-29,505	Closed	-$1.82M	–	64
2014 Q4	$1.82M	Buy	29,505 +2,215	+8%	+$109K	1.03%	35
2014 Q3	$1.06M	Buy	+27,290	New	+$967K	0.73%	36

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Light Asset Management's IONS Position: Q1 2021 in Review

First Light Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 179,601 shares — an estimated $10.2M sold.

First Light Asset Management first reported a position in IONS in Q3 2014 and held it in 19 quarters. The position peaked at $49.6M in Q1 2019. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

First Light Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
First Light Asset Management sold 179,601 Ionis Pharmaceuticals shares in Q1 2021, an estimated $10.2M.
First Light Asset Management first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 19 quarters.
First Light Asset Management's Ionis Pharmaceuticals position peaked at $49.6M in Q1 2019.
364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on First Light Asset Management's 13F filing for Q1 2021, filed 17 May 2021.